Liu, L.; Shi, H.; Shi, Y.; Wang, A.; Guo, N.; Tao, H.; Nahata, M.C.
Comparative Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity or Overweight: A Systematic Review and Network Meta-Analysis. Pharmaceuticals 2024, 17, 828.
https://doi.org/10.3390/ph17070828
AMA Style
Liu L, Shi H, Shi Y, Wang A, Guo N, Tao H, Nahata MC.
Comparative Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity or Overweight: A Systematic Review and Network Meta-Analysis. Pharmaceuticals. 2024; 17(7):828.
https://doi.org/10.3390/ph17070828
Chicago/Turabian Style
Liu, Ligang, Hekai Shi, Yufei Shi, Anlin Wang, Nuojin Guo, Heqing Tao, and Milap C. Nahata.
2024. "Comparative Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity or Overweight: A Systematic Review and Network Meta-Analysis" Pharmaceuticals 17, no. 7: 828.
https://doi.org/10.3390/ph17070828
APA Style
Liu, L., Shi, H., Shi, Y., Wang, A., Guo, N., Tao, H., & Nahata, M. C.
(2024). Comparative Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity or Overweight: A Systematic Review and Network Meta-Analysis. Pharmaceuticals, 17(7), 828.
https://doi.org/10.3390/ph17070828
